AP NEWS

Research Report Identifies Ironwood Pharmaceuticals, The AES, Accuray, Ball, Park Hotels & Resorts, and NeoGenomics with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

November 12, 2018

NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), The AES Corporation (NYSE:AES), Accuray Incorporated (NASDAQ:ARAY), Ball Corporation (NYSE:BLL), Park Hotels & Resorts Inc. (NYSE:PK), and NeoGenomics, Inc. (NASDAQ:NEO), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

IRWD DOWNLOAD: http://Fundamental-Markets.com/register/?so=IRWD AES DOWNLOAD: http://Fundamental-Markets.com/register/?so=AES ARAY DOWNLOAD: http://Fundamental-Markets.com/register/?so=ARAY BLL DOWNLOAD: http://Fundamental-Markets.com/register/?so=BLL PK DOWNLOAD: http://Fundamental-Markets.com/register/?so=PK NEO DOWNLOAD: http://Fundamental-Markets.com/register/?so=NEO

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), The AES Corporation (NYSE:AES), Accuray Incorporated (NASDAQ:ARAY), Ball Corporation (NYSE:BLL), Park Hotels & Resorts Inc. (NYSE:PK), and NeoGenomics, Inc. (NASDAQ:NEO) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 8th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

IRONWOOD PHARMACEUTICALS, INC. (IRWD) REPORT OVERVIEW

Ironwood Pharmaceuticals’ Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Ironwood Pharmaceuticals reported revenue of $65.69MM vs $86.83MM (down 24.35%) and analysts estimated basic earnings per share -$1.14 vs -$0.22. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ironwood Pharmaceuticals reported revenue of $298.28MM vs $273.96MM (up 8.88%) and analysts estimated basic earnings per share -$0.78 vs -$0.56. Analysts expect earnings to be released on February 21st, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.14. The estimated EPS forecast for the next fiscal year is $0.23 and is expected to report on February 21st, 2019.

To read the full Ironwood Pharmaceuticals, Inc. (IRWD) report, download it here: http://Fundamental-Markets.com/register/?so=IRWD

-----------------------------------------

THE AES CORPORATION (AES) REPORT OVERVIEW

The AES’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, The AES reported revenue of $2,837.00MM vs $2,693.00MM (up 5.35%) and analysts estimated basic earnings per share $0.15 vs $0.23 (down 34.78%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, The AES reported revenue of $10,530.00MM vs $10,281.00MM (up 2.42%) and analysts estimated basic earnings per share -$1.76 vs -$1.72. Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.43. The estimated EPS forecast for the next fiscal year is $1.31 and is expected to report on February 26th, 2019.

To read the full The AES Corporation (AES) report, download it here: http://Fundamental-Markets.com/register/?so=AES

-----------------------------------------

ACCURAY INCORPORATED (ARAY) REPORT OVERVIEW

Accuray’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Accuray reported revenue of $95.83MM vs $90.95MM (up 5.36%) and analysts estimated basic earnings per share -$0.11 vs -$0.11. For the twelve months ended June 30th, 2018 vs June 30th, 2017, Accuray reported revenue of $404.90MM vs $383.41MM (up 5.60%) and analysts estimated basic earnings per share -$0.28 vs -$0.36. Analysts expect earnings to be released on January 22nd, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.06. The estimated EPS forecast for the next fiscal year is $0.09 and is expected to report on August 15th, 2019.

To read the full Accuray Incorporated (ARAY) report, download it here: http://Fundamental-Markets.com/register/?so=ARAY

-----------------------------------------

BALL CORPORATION (BLL) REPORT OVERVIEW

Ball’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Ball reported revenue of $2,946.00MM vs $2,908.00MM (up 1.31%) and basic earnings per share $0.17 vs $0.14 (up 21.43%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ball reported revenue of $10,983.00MM vs $9,061.00MM (up 21.21%) and analysts estimated basic earnings per share $1.07 vs $0.83 (up 28.92%). Analysts expect earnings to be released on February 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.60. The estimated EPS forecast for the next fiscal year is $2.61 and is expected to report on February 6th, 2019.

To read the full Ball Corporation (BLL) report, download it here: http://Fundamental-Markets.com/register/?so=BLL

-----------------------------------------

PARK HOTELS & RESORTS INC. (PK) REPORT OVERVIEW

Park Hotels & Resorts’ Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Park Hotels & Resorts reported revenue of $652.00MM vs $688.00MM (down 5.23%) and analysts estimated basic earnings per share $0.26 vs $0.48 (down 45.83%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Park Hotels & Resorts reported revenue of $2,791.00MM vs $2,727.00MM (up 2.35%) and analysts estimated basic earnings per share $12.38 vs $0.67 (up 1,747.76%). Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.68. The estimated EPS forecast for the next fiscal year is $2.91 and is expected to report on March 7th, 2019.

To read the full Park Hotels & Resorts Inc. (PK) report, download it here: http://Fundamental-Markets.com/register/?so=PK

-----------------------------------------

NEOGENOMICS, INC. (NEO) REPORT OVERVIEW

NeoGenomics’ Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, NeoGenomics reported revenue of $69.10MM vs $59.14MM (up 16.84%) and analysts estimated basic earnings per share $0.02 vs -$0.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, NeoGenomics reported revenue of $258.61MM vs $244.08MM (up 5.95%) and analysts estimated basic earnings per share -$0.14 vs -$0.39. Analysts expect earnings to be released on February 20th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.04. The estimated EPS forecast for the next fiscal year is $0.17 and is expected to report on February 20th, 2019.

To read the full NeoGenomics, Inc. (NEO) report, download it here: http://Fundamental-Markets.com/register/?so=NEO

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

AP RADIO
Update hourly